End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
59.8 TWD | -0.83% | -2.76% | +37.31% |
Sales 2023 * | 3.7B 118M | Sales 2024 * | 4.14B 132M | Capitalization | 9.93B 315M |
---|---|---|---|---|---|
Net income 2023 * | 420M 13.34M | Net income 2024 * | 597M 18.96M | EV / Sales 2023 * | 2,68x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 2,40x |
P/E ratio 2023 * | 22,9x | P/E ratio 2024 * | 16,3x | Employees | - |
Yield 2023 * | 3,68% | Yield 2024 * | 5,85% | Free-Float | 58.58% |
More Fundamentals
* Assessed data
More news
More press releases
1 day | -0.83% | ||
1 week | -2.76% | ||
Current month | -2.76% | ||
1 month | -6.85% | ||
3 months | +6.79% | ||
6 months | -5.23% | ||
Current year | +37.31% |
1 week
59.70
63.40

1 month
59.60
65.70

Current year
43.10
75.70

1 year
43.10
75.70

3 years
33.00
75.70

5 years
27.65
75.70

10 years
27.65
87.40

Managers | Title | Age | Since |
---|---|---|---|
Pei Lin Lee
CEO | Chief Executive Officer | - | 2009 |
Yi Chun Chen
DFI | Director of Finance/CFO | - | 2011 |
Ming Lun Lee
COO | Chief Operating Officer | - | 2010 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yung Shun Chuang
BRD | Director/Board Member | - | 2014 |
Pei Lin Lee
CEO | Chief Executive Officer | - | 2009 |
Kuei Tuan Chen
BRD | Director/Board Member | - | 2012 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | -.--% | - | |
0.02% | 723 M€ | +13.40% | - | |
0.01% | 3,670 M€ | +8.07% | - | |
0.01% | 408 M€ | +5.88% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-07 | 59.8 | -0.83% | 795 915 |
23-12-07 | 60.3 | -0.99% | 767,253 |
23-12-06 | 60.9 | -1.77% | 1,359,754 |
23-12-05 | 62 | -0.48% | 1,549,449 |
23-12-04 | 62.3 | +1.80% | 1,672,683 |
End-of-day quote Taiwan Stock Exchange, December 07, 2023
More quotes
CHC Healthcare Group is a Taiwan-based investment holding company. The Company primarily involves in the agent distribution of radiation oncology, neurology, medical image and nuclear medical, as well as dental and ophthalmological equipment and instrument. The Company also offers related maintenance and leasing services, components and consumable materials and specialty consulting services. The Company deals with medical instrument with brands as Elekta, PTW, GE, Ashland, Megin, Leica, Hillrom, Sony, Ellex and Wexler, among others. The Company is also involved in the operation of pharmacy.
Calendar
2024-03-14
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
Sell
Buy

Mean consensus
BUY
Number of Analysts
2
Last Close Price
59.8TWD
Average target price
71TWD
Spread / Average Target
+18.73%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.31% | 319 M $ | |
-42.08% | 169 M $ | |
+78.64% | 56 M $ |